Audrey Goodwin
Internal Medicine · Edmond, OKNPI 1952661688
Payments from drug & device makers
Across 100 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$180
- Novo Nordisk$172
- AbbVie$149
- Merck$126
- Sanofi-aventis U.S. LLC$121
- Boehringer Ingelheim$119
- plus $648 from 17 others
What the payments were for
- Food & beverage$1,515100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $180 |
| Novo Nordisk | 10 | $172 |
| AbbVie | 8 | $149 |
| Merck | 9 | $126 |
| Sanofi-aventis U.S. LLC | 9 | $121 |
| Boehringer Ingelheim | 8 | $119 |
| Pfizer | 8 | $117 |
| Amgen | 6 | $104 |
| Lilly USA, LLC | 6 | $92 |
| Ironshore Pharmaceuticals Inc. | 5 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Amarin Pharma, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Abbott | 1 | $15 |
| Edwards Lifesciences | 1 | $15 |
| GSK | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
How this compares
$1,515 in reported general payments places this provider in the 70th percentile of 840 internal medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $72,440 |
| TrulicityDulaglutide | 26 | $54,587 |
| JardianceEmpagliflozin | 21 | $39,300 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $34,848 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 32 | $33,139 |
| MyrbetriqMirabegron | 23 | $18,341 |
| JanuviaSitagliptin Phosphate | 16 | $16,566 |
| FarxigaDapagliflozin Propanediol | 14 | $15,765 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $7,816 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 33 | $7,347 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 90 | $3,887 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 48 | $3,347 |
| Omeprazole | 116 | $3,299 |
| Gabapentin | 178 | $3,217 |
| Clonidine | 11 | $2,332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $172 | $72,44035 claims |
| Lilly USA, LLCTrulicity | $92 | $54,58726 claims |
| GSKTrelegy Ellipta, Shingrix | $14 | $42,19563 claims |
| Boehringer IngelheimJardiance | $119 | $39,30021 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $121 | $33,13932 claims |
| MerckJanuvia | $126 | $16,56616 claims |
| AstraZenecaFarxiga | $180 | $15,76514 claims |
| AbbVieSynthroid | $149 | $1,25217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 840 internal medicine providers in Oklahoma.
Other internal medicine in Edmond
- Todd KrehbielEdmond$21K
- Ashlee WaughEdmond$15K
- William MorganEdmond$13K
- Thomas KupiecEdmond$12K
- Al-Ola AbdallahTulsa$10.1M
- Melita TateTulsa$9.1M
- Sagila GeorgeOklahoma City$1.8M
- Ryan MorganOklahoma City$775K
- Renae MayerTulsa$766K
- George FreemanIdabel$742K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.